D. E. Shaw & Co., Inc. - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 79 filers reported holding REVANCE THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.25 and the average weighting 1.6%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,313,824
-81.7%
812,016
-59.6%
0.01%
-82.7%
Q2 2023$50,915,343
-31.0%
2,011,669
-12.2%
0.05%
-34.2%
Q1 2023$73,822,453
+198.7%
2,291,911
+71.2%
0.08%
+192.6%
Q4 2022$24,716,463
-37.7%
1,338,920
-8.9%
0.03%
-42.6%
Q3 2022$39,678,000
+251.1%
1,469,573
+79.7%
0.05%
+261.5%
Q2 2022$11,302,000
-31.5%
817,740
-3.4%
0.01%
-13.3%
Q1 2022$16,502,000
+93.0%
846,268
+61.5%
0.02%
+114.3%
Q4 2021$8,550,000
+3226.8%
523,918
+5570.1%
0.01%
Q3 2021$257,000
-82.0%
9,240
-80.8%
0.00%
-100.0%
Q2 2021$1,425,000
+463.2%
48,087
+438.3%
0.00%
Q4 2020$253,000
-68.1%
8,933
-71.7%
0.00%
-100.0%
Q3 2020$794,000
+193.0%
31,584
+184.3%
0.00%
Q2 2020$271,000
+48.9%
11,111
-9.7%
0.00%
Q1 2020$182,000
-35.2%
12,300
-43.3%
0.00%
Q2 2019$281,000
-40.1%
21,686
-27.1%
0.00%
-100.0%
Q1 2019$469,000
-76.8%
29,729
-70.4%
0.00%
-66.7%
Q4 2018$2,023,000
+24.9%
100,490
+54.1%
0.00%
+50.0%
Q3 2018$1,620,000
-24.3%
65,202
-16.4%
0.00%
-33.3%
Q2 2018$2,141,000
+648.6%
77,994
+739.7%
0.00%
Q1 2018$286,000
-81.9%
9,288
-79.0%
0.00%
-100.0%
Q4 2017$1,579,000
+611.3%
44,172
+312.2%
0.00%
Q4 2016$222,000
-76.7%
10,717
-80.4%
0.00%
-100.0%
Q1 2016$954,000
-82.5%
54,621
-65.8%
0.00%
-75.0%
Q4 2015$5,464,000
+622.8%
159,939
+529.7%
0.01%
+700.0%
Q3 2015$756,000
-43.4%
25,400
-39.2%
0.00%
-50.0%
Q2 2015$1,336,00041,7720.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Palo Alto Investors LP 4,415,689$86,106,0006.66%
Evolutionary Tree Capital Management, LLC 176,336$3,439,0002.39%
Essex Woodlands Management, Inc. 457,085$8,913,0002.16%
HealthCor Management, L.P. 1,423,425$27,757,0001.85%
RICE HALL JAMES & ASSOCIATES, LLC 1,112,325$21,690,0000.86%
Waypoint Capital Advisors, LLC 53,989$1,016,0000.60%
Antara Capital LP 679,600$13,252,0000.40%
Rhenman & Partners Asset Management AB 198,358$3,868,0000.38%
Walleye Capital LLC 505,701$9,861,0000.26%
Polar Capital Holdings Plc 2,456,497$47,902,0000.22%
View complete list of REVANCE THERAPEUTICS INC shareholders